These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 33157255)

  • 1. Therapeutic role of inflammasome inhibitors in neurodegenerative disorders.
    Lahooti B; Chhibber T; Bagchi S; Varahachalam SP; Jayant RD
    Brain Behav Immun; 2021 Jan; 91():771-783. PubMed ID: 33157255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A role of inflammasomes in the pathogenesis of neurological and mental diseases].
    Pirozhkov SV; Terebilina NN; Litvitskiy PF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12):81-91. PubMed ID: 30698567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
    Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
    Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting NLRP3 inflammasome for neurodegenerative disorders.
    Yao J; Wang Z; Song W; Zhang Y
    Mol Psychiatry; 2023 Nov; 28(11):4512-4527. PubMed ID: 37670126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of NLRP3 activation and pathology during neurodegeneration.
    Jose S; Groves NJ; Roper KE; Gordon R
    Int J Biochem Cell Biol; 2022 Oct; 151():106273. PubMed ID: 35926782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome.
    Shao QH; Zhang XL; Yang PF; Yuan YH; Chen NH
    Int Immunopharmacol; 2017 Aug; 49():155-160. PubMed ID: 28595078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis.
    Shao S; Chen C; Shi G; Zhou Y; Wei Y; Fan N; Yang Y; Wu L; Zhang T
    Pharmacol Ther; 2021 Nov; 227():107880. PubMed ID: 33901504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases.
    Possemato E; La Barbera L; Nobili A; Krashia P; D'Amelio M
    Ageing Res Rev; 2023 Jun; 87():101907. PubMed ID: 36893920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models.
    Das B; Sarkar C; Rawat VS; Kalita D; Deka S; Agnihotri A
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in mechanisms for NLRP3 inflammasomes regulation].
    Liu W; Guo WJ; Xu Q; Sun Y
    Yao Xue Xue Bao; 2016 Oct; 51(10):1505-12. PubMed ID: 29924571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases.
    Feng YS; Tan ZX; Wu LY; Dong F; Zhang F
    Biomed Pharmacother; 2021 Jun; 138():111428. PubMed ID: 33667787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies.
    Song L; Pei L; Yao S; Wu Y; Shang Y
    Front Cell Neurosci; 2017; 11():63. PubMed ID: 28337127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages.
    Jung SS; Moon JS; Xu JF; Ifedigbo E; Ryter SW; Choi AM; Nakahira K
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1058-67. PubMed ID: 25770182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.